top of page

SELECT PUBLICATIONS

A model of intratumor and interpatient heterogeneity explains clinical trials of curative combination therapy for lymphoma

Pomeroy and Palmer

Blood Cancer Discovery. 2025.

Ultrasensitive response explains the benefit of combination chemotherapy despite drug antagonism

Patterson, Pomeroy, and Palmer

Molecular Cancer Research. 2024.

Drug independence and the curability of cancer by combination chemotherapy

Pomeroy, Schmidt, Sorger, and Palmer

Trends in Cancer. 2022.

A predictive model of gene expression reveals the role of network motifs in the mating response of yeast

Pomeroy et al.

Science Signaling. 2021.

Synergistic drug combinations promote the development of resistance in acute myeloid leukemia

Mason-Osann, Pomeroy, Palmer, and Mettetal

Blood Cancer Discovery. 2024.

“R” U ready?: a case study using R to analyze changes in gene expression during evolution

Pomeroy et al.

Frontiers in Education. 2024.

COMPLETE LISTS OF PUBLICATIONS

bottom of page